title: An H1-histamine receptor antagonist decreases serum interleukin-31 levels in patients with atopic dermatitis.
authors.forename: A
authors.initials: A
authors.lastname: Otsuka
authors.forename: T
authors.initials: T
authors.lastname: Honda
authors.forename: H
authors.initials: H
authors.lastname: Doi
authors.forename: Y
authors.initials: Y
authors.lastname: Miyachi
authors.forename: K
authors.initials: K
authors.lastname: Kabashima
mesh_terms: D000328:Adult; D000368:Aged; D003876:Dermatitis, Atopic / Q000097:blood* / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use*; D005260:Female; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D007378:Interleukins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010147:Pain Measurement; D055815:Young Adult
chemical_list: D003984:Dibenzazepines; D006634:Histamine H1 Antagonists; C502187:IL31 protein, human; D007093:Imidazoles; D007378:Interleukins; C053090:epinastine